Relative benefit criteria for low-priced essential drugs questioned

Pharmaceutical business sources say that although the health ministry recently selected more 300 generics for cost compensation, the list of 400 essential drugs, which has selected by the government from April 2000, has not been fully enforced up to now, as 130 items (e.g., essential amino acid infusions, narcotics, etc.) benefited from pricing increase.

Market experts said that the governme...